Anchor price 94.23 on closest trading day on/after 2026-06-23. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-01 | King-Jones Heidy | officer | Option exercise | 28,933 | $14.50 | $420K |
| 2026-10-01 | King-Jones Heidy | officer | Sale | 400 | $89.24 | $36K |
| 2026-10-01 | King-Jones Heidy | officer | Sale | 16,605 | $90.35 | $1.50M |
| 2026-10-01 | King-Jones Heidy | officer | Sale | 7,228 | $91.35 | $660K |
| 2026-10-01 | King-Jones Heidy | officer | Sale | 2,100 | $92.70 | $195K |
| 2026-10-01 | King-Jones Heidy | officer | Sale | 2,600 | $93.46 | $243K |
| 2026-10-01 | Turtle Cameron | director, officer | Sale | 600 | $89.14 | $53K |
| 2026-10-01 | Turtle Cameron | director, officer | Sale | 2,683 | $90.10 | $242K |
| 2026-10-01 | Turtle Cameron | director, officer | Sale | 2,638 | $91.49 | $241K |
| 2026-10-01 | Turtle Cameron | director, officer | Sale | 3,989 | $92.31 | $368K |
| 2026-10-01 | Turtle Cameron | director, officer | Sale | 4,990 | $93.37 | $466K |
| 2026-10-01 | Turtle Cameron | director, officer | Sale | 100 | $93.91 | $9K |
| 2026-10-01 | Burrows Scott L | officer | Option exercise | 7,500 | $14.50 | $109K |
| 2026-10-01 | Burrows Scott L | officer | Sale | 600 | $89.07 | $53K |
| 2026-10-01 | Burrows Scott L | officer | Sale | 1,500 | $90.27 | $135K |
| 2026-10-01 | Burrows Scott L | officer | Sale | 2,100 | $91.92 | $193K |
| 2026-10-01 | Burrows Scott L | officer | Sale | 3,071 | $92.95 | $285K |
| 2026-10-01 | Burrows Scott L | officer | Sale | 229 | $93.57 | $21K |
| 2026-09-30 | Burrows Scott L | officer | Option exercise | 17,500 | $14.50 | $254K |
| 2026-09-30 | Burrows Scott L | officer | Sale | 17,500 | $89.89 | $1.57M |
| 2026-09-02 | King-Jones Heidy | officer | Option exercise | 400 | $14.50 | $6K |
| 2026-09-02 | King-Jones Heidy | officer | Sale | 400 | $90.00 | $36K |
| 2026-09-02 | Burrows Scott L | officer | Sale | 18,232 | $89.35 | $1.63M |
| 2026-09-01 | King-Jones Heidy | officer | Option exercise | 27,999 | $14.50 | $406K |
| 2026-09-01 | King-Jones Heidy | officer | Sale | 4,845 | $86.40 | $419K |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-10-09 | SCHEDULE 13D/A | Fairmount Funds Management LLC | 9.99% | 9,354,200 | view → |
| 2026-10-01 | SCHEDULE 13G | Paradigm Biocapital Advisors LP | — | — | view → |
| 2023-12-11 | SC | Fairmount Funds Management LLC | — | — | view → |
| 2022-02-10 | SC | BAKER BROS. ADVISORS LP | — | — | view → |
| 2021-03-19 | SC | BAKER BROS. ADVISORS LP | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-10-15 | SCHEDULE 13D | Alaunos Therapeutics, Inc. | 19.99% | 858,789 | view → |
| 2026-10-09 | SCHEDULE 13D/A | SPYRE THERAPEUTICS, INC. | 9.99% | 9,354,200 | view → |
| 2026-09-11 | SCHEDULE 13D | Korsana Biosciences, Inc. | 19.99% | 9,103,729 | view → |
| 2026-09-03 | SCHEDULE 13D/A | Apogee Therapeutics, Inc. | — | 0 | view → |
| 2026-07-20 | SCHEDULE 13D/A | Crescent Biopharma, Inc. | — | 6,593,385 | view → |
| 2026-07-01 | SCHEDULE 13D/A | ORUKA THERAPEUTICS, INC. ORKA | 19.50% | 14,553,895 | view → |
| 2026-06-23 | SCHEDULE 13D/A | Apogee Therapeutics, Inc. APGE | 9.99% | 6,713,519 | view → |
| 2026-06-09 | SCHEDULE 13D/A | Jade Biosciences, Inc. JBIO | 19.99% | 14,069,494 | view → |
| 2026-05-13 | SCHEDULE 13D/A | Viridian Therapeutics, Inc.\DE VRDN | — | 17,201,800 | view → |
| 2026-01-22 | SCHEDULE | Cogent Biosciences, Inc. COGT | 9.90% | 16,261,918 | view → |
| 2026-01-22 | SCHEDULE | Apogee Therapeutics, Inc. APGE | 9.99% | 6,047,027 | view → |
| 2025-10-14 | SCHEDULE | Apogee Therapeutics, Inc. APGE | 9.99% | 5,776,881 | view → |
| 2025-09-15 | SCHEDULE | Dianthus Therapeutics, Inc. /DE/ DNTH | 9.90% | 4,052,052 | view → |
| 2025-03-10 | SCHEDULE | Oruka Therapeutics, Inc. ORKA | 19.99% | 8,511,824 | view → |
| 2024-04-01 | SC | Cogent Biosciences, Inc. COGT | — | — | view → |
| 2024-04-01 | SC | Dianthus Therapeutics, Inc. /DE/ DNTH | — | — | view → |
| 2024-04-01 | SC | Viridian Therapeutics, Inc.\DE VRDN | — | — | view → |
| 2024-04-01 | SC | Apogee Therapeutics, Inc. APGE | — | — | view → |
| 2023-12-11 | SC | Spyre Therapeutics, Inc. SYRE | — | — | view → |
| 2023-06-13 | SC | Cogent Biosciences, Inc. COGT | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →